Vistagen Therapeutics Stock Forecast

Sell candidate since Jun 02, 2026 Loss -6.22%

The VistaGen Therapeutics Inc stock price fell by -5.51% on the last day (Friday, 5th Jun 2026) from $0.576 to $0.544. During the last trading day the stock fluctuated 7.25% from a day low at $0.540 to a day high of $0.580. The price has fallen in 6 of the last 10 days and is down by -14.63% for this period. Volume has increased on the last day by 197 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 490 thousand shares were bought and sold for approximately $266.26 thousand.

The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $0.546. A reaction back to this level may hold a second chance to get out before further falls.

VTGN Signals & Forecast

There are few to no technical positive signals at the moment. The VistaGen Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.596 and $0.613. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -16.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). VistaGen Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

VistaGen Therapeutics Inc finds support from accumulated volume at $0.543 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0392 between high and low, or 7.25%. For the last week, the stock has had daily average volatility of 8.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VTGN) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect VistaGen Therapeutics Inc to open at $0.555, and during the day (based on 14 day Average True Range), to move between $0.521 and $0.567, which gives a possible trading interval of +/-$0.0458 (+/-8.78%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 8.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.543 (0.24%) than the resistance at $0.580 (6.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is VistaGen Therapeutics Inc stock A Buy?

The VistaGen Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe VistaGen Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.443 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.555 ( 1.97%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk